Rivernorth Capital Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-580,432
| Closed | -$6.01M | – | 515 |
|
|
2023
Q3 | $6.01M | Buy |
580,432
+74,325
| +15% | +$770K | 0.31% | 71 |
|
|
2023
Q2 | $5.23M | Sell |
506,107
-976
| -0.2% | -$10.1K | 0.26% | 81 |
|
|
2023
Q1 | $5.14M | Hold |
507,083
| – | – | 0.25% | 82 |
|
|
2022
Q4 | $5.05M | Buy |
507,083
+308,565
| +155% | +$3.07M | 0.23% | 90 |
|
|
2022
Q3 | $1.94M | Buy |
198,518
+1,913
| +1% | +$18.7K | 0.09% | 246 |
|
|
2022
Q2 | $1.91M | Hold |
196,605
| – | – | 0.08% | 244 |
|
|
2022
Q1 | $1.91M | Sell |
196,605
-3,385
| -2% | -$32.9K | 0.07% | 247 |
|
|
2021
Q4 | $1.94M | Hold |
199,990
| – | – | 0.08% | 219 |
|
|
2021
Q3 | $1.94M | Buy |
+199,990
| New | +$1.94M | 0.1% | 167 |
|